Mastermyne Group reported a 13% increase in annual revenue to AUD 237.7 million for the fiscal year ended June 30, 2026, surpassing the upper end of guidance provided in February. Underlying earnings before interest, taxes, depreciation and amortization climbed 47% to AUD 20.3 million, while underlying net profit before tax surged 148% to AUD 15.7 million.
The company’s net cash balance rose to AUD 46.5 million from AUD 29.1 million a year earlier, reflecting a 60% improvement. Total cash increased by AUD 16.8 million during the year to AUD 47.2 million as of June 30. Net operating cash flow advanced 20% to AUD 20.3 million. Mastermyne’s order book expanded by 38% year-over-year to AUD 432 million, with the near-term project pipeline up 67% to AUD 1.5 billion.
Revenue visibility for the coming fiscal year remains strong, with approximately AUD 200 million already secured. This includes about AUD 155 million from existing contracts and AUD 40-45 million from the first year of the Dendrobium project with GM³, a six-year agreement valued at up to AUD 255 million. The company’s strata consolidation segment now accounts for 30% of group revenue, up from 26% in the prior year.
Despite the financial performance, Mastermyne shares fell 6.67% to AUD 0.56, extending a decline from the prior session’s close of AUD 0.60. The stock has traded between AUD 0.12 and AUD 0.625 over the past 52 weeks. The board declared a nil final dividend for FY 2026, opting to retain capital for organic growth and potential acquisitions.
Workforce growth continued, reaching 689 employees by June 30 from 640 a year earlier, with further hiring expected as Mastermyne approaches a 1,000-person headcount. The company maintained capital expenditure at roughly 2% of revenue and reported a current ratio of 1.61. Available liquidity totaled AUD 76 million, supported by an undrawn AUD 30 million working capital facility extended through July 2028.
